NASDAQ:PGNX
Delisted

Progenics Pharmaceuticals Inc. Stock Forecast

$4.10
+0 (+0%)
At Close: Sep 04, 2020
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Progenics Pharmaceuticals Inc. Stock and on which exchange is it traded?
The symbol for Progenics Pharmaceuticals Inc. is PGNX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Progenics Pharmaceuticals Inc. Stock?
Progenics Pharmaceuticals Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Progenics Pharmaceuticals Inc. Stock?
Progenics Pharmaceuticals Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Progenics Pharmaceuticals Inc. Stock.

What's the current price of Progenics Pharmaceuticals Inc. Stock?
As of the end of day on the 2020-09-04, the price of an Progenics Pharmaceuticals Inc. (PGNX) share was $4.10.

What is the 52-week high and low for Progenics Pharmaceuticals Inc. Stock?
The 52-week high for Progenics Pharmaceuticals Inc. Stock is $6.37 and the 52-week low is $1.89.
Click to get the best stock tips daily for free!

About Progenics Pharmaceuticals Inc.

Progenics Pharmaceuticals. Progenics Pharmaceuticals, Inc. develops medicines for oncology in the United States and internationally. The company’s primary clinical-stage product candidates include Azedra, a radiotherapeutic product candidate, which is in Phase IIb clinical trial under special protocol assessment for the treatment of pheochromocytoma and paraganglioma; 1404, a technetium-99m labeled small molecule that has completed Phase II testing, as well as acts as an ... PGNX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT